Fem-Dophilus® contains two patented and clinically documented probiotic strains, Lactobacillus rhamnosus, GR-1®and Lactobacillus reuteri, RC-14®, discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech. Over 25 years of research supports the oral use of GR-1® and RC-14®to colonize and promote vaginal and urinary tract health.* A special manufacturing process protects the probiotic strains inFem-Dophilus® from stomach acid and enhances probiotic bacterial survival to the lower intestine.*
GR-1®/RC-14® and VAGINAL FLORA (also called microbiota)
In one of the randomized clinical trials, 75% of women in the GR-1®/RC-14® probiotic group experienced significant improvement in vaginal flora composition, while only 34% of women in the placebo (non-probiotic) group experienced similar improvement.
Martinez, et al. Can J Microbiol 2009;55:133-138
- Oral Probiotic for Natural Vaginal Health*
- 25+Years of Research and Clinical Studies For Vaginal and Urinary Tract Health*
- More Than 20 Studies Demonstrating Safety and Efficacy*
- Patented Lactobacilli: GR-1® and RC-14®
- Prevention Magazine: Top 10 Breakthrough '07
For maintenance, take 1 capsule orally per day, preferably with a meal and a glass of water, and increase to 2 capsules per day as needed or take as directed by your qualified healthcare professional. If your healthcare professional recommends taking this product in conjunction with antibiotics, take at least 1-2 hours after taking the medication.
Maltodextrin (non-GMO source), cellulose, magnesium stearate (vegetable source). Capsule consists of hydroxypropylmethylcellulose and titanium dioxide.
No wheat, gluten, soybeans, dairy, egg, fish/shellfish, or peanuts/tree nuts.
Free of major allergens.
Suitable for vegetarians/vegans.
RC-14® and GR-1® are registered trademarks of Chr. Hansen A/S.
† Under license from Chr. Hansen A/S and protected by Chr. Hansen A/S patents of the WO 00/35465 patent family, and others.
Made in Denmark by Chr. Hansen A/S